<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Reactive <z:mp ids='MP_0003354'>astrogliosis</z:mp> is the most prominent macroglial response to diverse forms of <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> injury </plain></SENT>
<SENT sid="1" pm="."><plain>We assessed a potential role for the extracellular signal-regulated kinase/<z:chebi fb="0" ids="52290">mitogen</z:chebi>-activated protein kinase (ERK/MAPK) pathway because it represents a common effector for several major families of transmembrane receptors implicated in <z:mp ids='MP_0003354'>astrogliosis</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Immunohistochemical detection of activated ERK/MAPK in a series of human neurosurgical specimens utilizing phosphorylation state-dependent antibodies consistently revealed intense immunoreactivity in reactive astrocytes in both <z:hpo ids='HP_0011011'>subacute</z:hpo> and <z:hpo ids='HP_0011010'>chronic</z:hpo> lesions, including <z:mpath ids='MPATH_124'>infarct</z:mpath>, mechanical trauma, <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e>, and progressive multifocal <z:hpo ids='HP_0002352'>leukoencephalopathy</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Neurons, oligodendroglia, and most inflammatory cells showed little or no detectable activation </plain></SENT>
<SENT sid="4" pm="."><plain>These observations suggest a testable hypothesis: activation of the ERK/MAPK pathway is an obligatory step for the triggering and/or persistence of reactive <z:mp ids='MP_0003354'>astrogliosis</z:mp> </plain></SENT>
</text></document>